Search
Study shows hunger-blocking hormone levels change with eating, obesity: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/hunger-hormone-blocker.html
The hormone LEAP2, which naturally blocks the “hunger” hormone ghrelin, is elevated in people with obesity, especially after eating – raising hopes for a treatment that could one day more effectively reduce appetite and, hence, obesity.
UTSW Research: Diagnosing Alzheimer’s, timed radiation therapy, and more
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-research-roundup.html
Studies look at measuring blood flow velocity, a treatment strategy for non-small cell lung cancer, and the body’s response to airborne pathogens.
Largest Texas high schools to report all concussions to statewide registry: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/texas-high-schools-report-concussions.html
Starting this fall, the biggest public high schools in Texas are required to report all sports concussions to a central database as part of one of the nation’s largest statewide endeavors to track brain injuries in youth athletics.
Biomarker blood test could reveal high risk heart patients in need of treatment: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/biomarker-blood-test.html
A new blood test for protein biomarkers could identify high risk heart patients.
Magnets offer alternative for patients with major depression: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/magnets-major-depression.html
UT Southwestern is the only clinical trial site in the U.S. using a new form of brain stimulation to treat major depression.
Three-drug combo improves lung function in most common genetic form of cystic fibrosis: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/three-drug-combo-cystic-fibrosis.html
A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
Single-incision surgery speeds recovery for cancer patient: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/single-incision-surgery-speeds-recovery.html
A new robotic surgery device allows for all of the necessary surgical tools to be inserted through one 1-inch hole, whereas standard laparoscopic surgery requires five or six small incisions.
New interactive map first to show life expectancy of Texans by ZIP code, race, and gender: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/life-expectancy-texas-zipcode.html
UT Southwestern Medical Center scientists for the first time have calculated and mapped life expectancy by gender and race/ethnicity down to the ZIP code and county levels in Texas.
State’s investment in cancer research has helped draw top talent to UTSW : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/dec-cprit-recruitment-grants-cancer-research.html
Early in his career, Ralf Kittler, Ph.D., attracted the attention of academic leaders at UT Southwestern Medical Center with his studies of DNA transcription factors and their role in tumor growth and suppression.
UTSW researchers identify new mechanism to reduce inflammation: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/reducing-inflammation.html
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.